CCS adapting to COVID-19 realities to support Canadians during and after the pandemic
Stay informed and inspired!
Subscribe to our monthly e-newsletter×
Giving higher doses of a cancer drug might lead to more robust responses, but this does not mean small doses are less effective. Researchers from Stanford University showed that small doses of immune-stimulating drugs packed a big punch when given to mice, eliminating body-wide tumours. A clinical trial is underway to investigate this new therapy in people with lymphoma. Learn more in an article from Stanford Medicine News Centre.